Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4295559 Target Snapshot

Dipeptidyl peptidase IV · SINGLE PROTEIN · Porphyromonas gingivalis

76Compounds
5Assays
3Approved Drugs
77.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O31048. Use UniProt O31048 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O31048 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dipeptidyl peptidase IV as ChEMBL target CHEMBL4295559, mapped to UniProt O31048. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dipeptidyl peptidase IV
SINGLE PROTEIN · Porphyromonas gingivalis
As of 2026-09-14
ChEMBL target ID
CHEMBL4295559
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O31048
Dipeptidyl peptidase IV
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dipeptidyl peptidase IV is the right protein anchor across sources, using UniProt O31048 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDipeptidyl peptidase IV
UniProt AccessionO31048
Component TypeProtein
Sequence Length723 aa

Dipeptidyl peptidase IV

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dipeptidyl peptidase IV, mapped to UniProt O31048. Sequence length is 723 aa.

Mapped IDO31048
Review nameDipeptidyl peptidase IV
OrganismPorphyromonas gingivalis
Clinical Profile

Clinical Phase Distribution

3
Approved
Assay Mix

Activity Type Distribution

IC5076.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL142703 7.77 Ki 17.0 Approved
CHEMBL4175831 7.1 IC50 79.0 Preclinical
CHEMBL4176189 6.85 IC50 140.0 Preclinical
CHEMBL471547 6.64 IC50 230.0 Preclinical
CHEMBL471747 6.52 IC50 300.0 Preclinical
CHEMBL471546 6.51 IC50 310.0 Preclinical
CHEMBL471731 6.48 IC50 330.0 Preclinical
CHEMBL4168495 6.32 IC50 480.0 Preclinical
CHEMBL4169745 6.24 IC50 580.0 Preclinical
CHEMBL4167565 6.1 IC50 800.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
5
5.5
4
6.0
4
6.5
1
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VILDAGLIPTIN
CHEMBL142703
Approved 2007
Assay Landscape

Assay Landscape

5
Total Assays
30
Tested Compounds
1
Assay Types
Binding — 5 assays, 30 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 30 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine